Ancestim Unknown Status Phase 0 Trials for Myelodysplasia Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment0
clinicaltrials.gov IdentifierTitleDrugs
NCT00434239Lenalidomide and Recombinant Human Stem Cell Factor for Treatment of Myelodysplasia